Dr Rohan Hockings manages a special purpose acquisition fund within the health care sector. Prior to undertaking this role, he has worked in a global management consulting firm, within the equity capital markets team at a national law firm and as a medical practitioner. He has a strong interest in both venture capital and private equity, and the role of each in the delivery of better health outcomes.
In 2022, Mr Hockings was a recipient of the Business News 40under40 Awards, a finalist in its First Amongst Equals category, and winner of the medium-sized business category his work in leading PYC Therapeutics to developing precision medications for retinitis pigmentosa and other eye diseases.